Skip to main content

Table 2 Multivariate analysis for PFS

From: IL-6 as new prognostic factor in patients with advanced cutaneous squamous cell carcinoma treated with cemiplimab

Covariate

p-value

HR

95% CI of Exp(b)

Gender

0.489

1.5719

0.4368 to 5.6570

IL6

0.02*

12.957

1.5025 to 111.7340

ORR

0.013*

0.1795

0.0464 to 0.6948

previous treatment

0.295

1.9075

0.5701 to 6.3831

  1. * Correlation is significant at the 0.05 level
Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us